Noradrenaline reuptake inhibitors vs placebo
QoL · adults with schizophrenia
1 finding from 1 review
- Selective noradrenaline reuptake inhibitors for schizophrenia 2018 · Cochrane Headline outcomes onlyno estimate extracted1 study · 114 participantsVery low